For the Inventor, By the Inventor

Enter assignee name

Braunschweig, Germany

Helmholtz-Zentrum Fur Infektionsforschung Gmbh

USPTO Granted Patents = 23

CIPO Patents = 5

EPO Patents = 58

Forward Citations = 21

Loading Chart...

Loading Chart...

107 inventors (with patents filed for the assignee):

Heinrich Steinmetz (5 out of 18 patents)

Rolf Müller (5 out of 13 patents)

Rolf Wolfgang Hartmann (5 out of 17 patents)

4. Jennifer Herrmann (4 out of 5 patents)

5. Kathrin Mohr (4 out of 4 patents)

6. Andreas Kirschning (4 out of 7 patents)

7. Klaus Gerth (4 out of 14 patents)

8. Mostafa Hamed (4 out of 4 patents)

9. Stephan Hüttel (3 out of 3 patents)

10. Sascha Baumann (3 out of 3 patents)

11. Franziska Gille (3 out of 3 patents)

12. Ritesh Raju (3 out of 3 patents)

13. Walid A M Elgaher (3 out of 3 patents)

14. Maria Moreno (3 out of 3 patents)

15. Liang Liang Wang (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 11883387 - PqsR inverse agonists (2024-01-30),

2. 11839658 - Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function (2023-12-12),

3. 11365201 - Chlorotonil derivatives (2022-06-21),

4. 11357752 - Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders (2022-06-14),

5. 11331371 - Labyrinthopeptins as anti-viral agents (2022-05-17),

6. 11236135 - and immunogenic composition containing the same as well as its use (2022-02-01),

7. 11225503 - Crystobactamides (2022-01-18),

8. 10793600 - Cystobactamides (2020-10-06),

9. 10519099 - Cystobactamides (2019-12-31),

10. 10472326 - PQSR modulators (2019-11-12),

11. 10407398 - Inhibitors ofLecB (2019-09-10),

12. 10188682 - Medicament for liver regeneration and for treatment of liver failure (2019-01-29),

13. 9458200 - Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles (2016-10-04),

14. 9453203 - Methods and vectors for cell immortalisation (2016-09-27),

15. 8956612 - Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker (2015-02-17),

Helmholtz Centre for Infection Research (HZI) is a world-leading research institute in the field of infection biology. Based in Brunswick, Germany, HZI conducts cutting-edge research to understand the mechanisms of infectious diseases and develop new strategies for prevention and treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

23 Patents

#6 in Braunschweig

#2,005 in Germany

#26,841 in the World

Braunschweig, Germany

Helmholtz-Zentrum Fur Infektionsforschung Gmbh

Forward Citations = 21

107 inventors:

Heinrich Steinmetz (5 out of 18 patents)

Rolf Müller (5 out of 13 patents)

Rolf Wolfgang Hartmann (5 out of 17 patents)

4. Jennifer Herrmann (4 out of 5 patents)

5. Kathrin Mohr (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…